American Portfolios Advisors Aditxt, Inc. Transaction History

American Portfolios Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Mar 20, 2023	BUY	$0.13 - $0.46 $130 - $460	1,000 New	1,000 $143,000
Q1 2022 Mar 21, 2023	BUY	$0.34 - $0.58 $340 - $580	1,000 New	1,000 $457,000
Q4 2021 Mar 21, 2023	BUY	$0.54 - $2.51 $540 - $2,510	1,000 New	1,000 $536,000
Q3 2021 Mar 22, 2023	BUY	$1.54 - $3.04 $2,310 - $4,560	1,500 New	1,500 $2.54 Million
Q2 2021 Mar 22, 2023	BUY	$2.2 - $3.2 $2,200 - $3,200	1,000 New	1,000 $2.59 Million
Q1 2021 Mar 22, 2023	BUY	$2.08 - $5.26 $2,080 - $5,260	1,000 New	1,000 $2.55 Million

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $1.41M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.